An ETH-LAD trip with unfavourable consequences: A case report.
Numerous analogues of the psychedelic and internationally controlled hallucinogen LSD have been described; however, only a limited number have been systematically investigated. This report presents the first case with an analytically confirmed ingestion of ETH-LAD (6-ethyl-6-nor-
- Authors
- Nadler J, Sommer M, Zschiesche A, Stürzebecher A, Grumann C, Auwärter V, Hermanns-Clausen M
- Journal
- British journal of clinical pharmacology
- Published
- 2026-08-07
- DOI
- 10.1002/bcp.70776
- PMID
- 42568216
- Content type
- Paper
- Authority
- Academic
Abstract
Numerous analogues of the psychedelic and internationally controlled hallucinogen LSD have been described; however, only a limited number have been systematically investigated. This report presents the first case with an analytically confirmed ingestion of ETH-LAD (6-ethyl-6-nor-lysergic acid diethylamide), the N-ethyl derivative of LSD. An adolescent patient developed moderate to severe symptoms as acute aggression, agitation, unconsciousness, multiple traumatic injuries, metabolic disturbances and persistent psychosis following ETH-LAD ingestion and required intensive medical therapy with unexpected findings. The concentration of the hallucinogenic new psychoactive substance in serum was determined with 38 ng mL-1. After 17 days of hospitalization, the patient was transferred to a psychiatric clinic for further treatment. Physicians must be aware that ETH-LAD ingestion may, unlike LSD, lead to severe toxic effects, requiring intensive care.
Citation
Nadler J, Sommer M, Zschiesche A, Stürzebecher A, Grumann C, Auwärter V, Hermanns-Clausen M (2026) An ETH-LAD trip with unfavourable consequences: A case report.. British journal of clinical pharmacology. doi:10.1002/bcp.70776
DOI: 10.1002/bcp.70776
Indexed by the DMT Code Research Bibliography, an open, stance scored library (CC-BY-4.0).